PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol

BACKGROUND: As disease-modifying therapies (DMTs) for Alzheimer's disease (AD) are becoming a reality, there is an urgent need to select cost-effective tools that can accurately identify patients in the earliest stages of the disease. Subjective Cognitive Decline (SCD) is a condition in which i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzeo, Salvatore, Lassi, Michael, Padiglioni, Sonia, Vergani, Alberto Arturo, Moschini, Valentina, Scarpino, Maenia, Giacomucci, Giulia, Burali, Rachele, Morinelli, Carmen, Fabbiani, Carlo, Galdo, Giulia, Amato, Lorenzo Gaetano, Bagnoli, Silvia, Emiliani, Filippo, Ingannato, Assunta, Nacmias, Benedetta, Sorbi, Sandro, Grippo, Antonello, Mazzoni, Alberto, Bessi, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422810/
https://www.ncbi.nlm.nih.gov/pubmed/37573339
http://dx.doi.org/10.1186/s12883-023-03347-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422810/
https://www.ncbi.nlm.nih.gov/pubmed/37573339
http://dx.doi.org/10.1186/s12883-023-03347-8

Ejemplares similares